On 29th September 2022, we brought together market access professionals from across Pharma and Medtech for our NHS Engagement Symposium: ‘People, pathways and payments – Mastering the key pillars of…
Read More
Tom Clarke (Director, NHS Insight & Interaction) explores what new integrated care legislation means for UK market access and for industry engagement with NHS decision-makers across England. July 1st saw...
Read More
Patient-centric design, ingenuity and a resilient drive to get new technologies to market were all on display at Medtech Innovation Expo. On 8th–9th June 2022 Calum Jones, Lily Westbrook and...
Read More
People, pathways, and payments – Mastering the key pillars of NHS engagement in 2023 Pharma and Medtech market access professionals joined us and our guest speakers from across the NHS...
Read More
Specialised services have long been the subject of debate around their place in Integrated Care Systems (ICSs), who will run them and how will they be funded. On 31st May...
Read More
We sit down with Emily Mair to learn more about her work as an Associate Consultant and how her career has developed, following earlier commercial roles. She shares her highlights...
Read More
On 13th April NHS England published the initial 2022/23 budgets of the 42 Integrated Care Boards (ICBs) expected to go live from 1st July 2022, subject to legislative approval. The...
Read More
NHS England published its 2022/23 National Tariff Payment System on 31st March 2022, a day before the new NHS financial year. The system provides guidance for the continued running of...
Read More
Our experts in health economics, value communication, design and digital discussed how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams...
Read More
Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how...
Read More
